“Ketamine for Depression: Is the Hype Holding Up?”
Dr. Richard C. Shelton, MD
Charles Byron Ireland Chair of Psychiatric Research
Department of Psychiatry and Behavioral Neurobiology
The University of Alabama at Birmingham
Thursday, May 6, 2021
Via Zoom Presentation 12:00pm-1:00pm (CST)
Contact us at email@example.com to receive the Zoom link for the presentation.
At the conclusion of the presentation attendees will be able to:
- Participants will have a deeper understanding of the basic pathophysiology of depression and how this is addressed by ketamine.
- Participants will be able to articulate a clear understanding of the clinical trial evidence for both ketamine and intranasal esketamine.
- Audience members will understand the risks and side effects of ketamine and esketamine treatment and will be able to describe them accurately and thoroughly to their patients.
- Participants will be able to articulate the limitations of ketamine treatment and controversies surrounding it.
DISCLOSURE: Dr. Shelton has disclosures which need to be revealed. He will not be discussing any off-label uses of products.
Accreditation: The University of Tennessee College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit: The University of Tennessee College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate only with the extent of their participation.
Hope to see you there!